SCHEMBL104151

SCHEMBL104151

O=C(O)c1ccc(F)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.50
LMNA P02545 2/20 0.48
RAB9A P51151 2/20 0.48
HTT P42858 2/20 0.48
MAPK1 P28482 1/20 0.48
PGR P06401 1/20 0.47
TSHR P16473 3/20 0.46
TP53 P04637 1/20 0.46
KDM4E B2RXH2 3/20 0.45
GAA P10253 2/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
PTGS2 P35354 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31302316 1.00 TTR (0.50) TTRLMNARAB9AHTTMAPK1
Hydrochloric Acid SCHEMBL6520005 0.98 TTR (0.48) TTRLMNARAB9AHTTMAPK1
Bromide SCHEMBL11166294 0.98 TTR (0.48) TTRLMNARAB9AHTTMAPK1
Fluoride SCHEMBL11181401 0.98 TTR (0.48) TTRLMNARAB9AHTTMAPK1
Trichloroacetic Acid SCHEMBL7814387 0.89 TTR (0.41) TTRLMNARAB9AHTTMAPK1
SCHEMBL30817696 0.84 ALDH1A1 (0.52) RAB9APGRTSHRCA1CA2
SCHEMBL10884738 0.83 CES2 (0.52) TTRRAB9APGRCES2CES1
SCHEMBL10555693 0.83 CES2 (0.45) RAB9APGRCA1CA2CES2
SCHEMBL286942 0.83 HTT (0.53) TTRLMNARAB9AHTTMAPK1
SCHEMBL9215548 0.83 NPC1 (0.47) RAB9APGRCA1CA2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 713 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
CN-114057724-B BTK inhibitor 鲁南制药集团股份有限公司 2025-01-03 CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-114057724-A BTK inhibitor 鲁南制药集团股份有限公司 2022-02-18 CN claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 US claimed
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES Indiana University Research and Technology Corpora tion (US) 2016-06-23 US claimed
US-9217012-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-12-22 US claimed
CN-103183647-A Novel preparation method of 3-{[2-[3-oxygen-(1,2-benzisothiazole-6-yl)methoxyl-5-(2-hydroxy-4-cyclopentyloxyl)]phenyl}propionic acid TIANJIN INT JOINT ACADEMY BIOTECHNOLOGY & MEDICINE 2013-07-03 CN claimed
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) 2012-04-12 US claimed
WO-2010118241-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2010-10-14 WO claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
EP-0048375-B1 PROCESS FOR THE PREPARATION OF 3-BROMO-4-FLUORO-BENZOIC ACID BAYER AG (DE) 1983-09-07 EP claimed
US-4393232-A Preparation of 3-bromo-4-fluoro-benzoic acid BAYER AKTIENGESELLSCHAFT (DE) 1983-07-12 US claimed
US-4386035-A INSECTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1983-05-31 US claimed
EP-0024516-B1 4-FLUORO-3-BROMOBENZOYL FLUORIDE, PROCESS FOR ITS PREPARATION AND FOR THE PREPARATION OF 4-FLUORO-3-BROMOBENZOIC ACID THEREFROM BAYER AG (DE) 1982-07-28 EP claimed
EP-0048914-A1 Process for the preparation of 3-bromo-4-fluorobenzyl alcohol, intermediate products therefor, and process for the preparation of these intermediate products BAYER AG (DE) 1982-04-07 EP claimed
EP-0048375-A1 Process for the preparation of 3-bromo-4-fluoro-benzoic acid BAYER AG (DE) 1982-03-31 EP claimed
EP-0024516-A1 4-Fluoro-3-bromobenzoyl fluoride, process for its preparation and for the preparation of 4-fluoro-3-bromobenzoic acid therefrom BAYER AG (DE) 1981-03-11 EP claimed
EP-0017882-A1 Process for the preparation of 3-phenoxy-4-fluoro-benzoic acid BAYER AG (DE) 1980-10-29 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS TTR 347/4885LMNA 4734/4885RAB9A 2114/4885
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS TTR 347/4885LMNA 4734/4885RAB9A 2114/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 TTR 22/4885LMNA 2024/4885RAB9A 789/4885
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS TTR 347/4885LMNA 4734/4885RAB9A 2114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.